Inactive Instrument
Aimmune Therapeutics, Inc. Stock
Stocks
AIMT
US00900T1079
Biotechnology & Medical Research
| 1 day | -0.29% |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/13/20 | Others | Director | 109,372 | 0.1671% | ||
| 10/13/20 | Nestle Health Science SA (Private Equity)
| Buy | Company | 54,117,287 | 82.6848% | |
| 10/10/20 | Tender | General Counsel | 391,686 | 0.5984% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.29% | +0.20% | - | - | 2.27B | |
| -0.31% | +3.56% | +46.40% | +100.50% | 70.89B | |
| +0.39% | +1.82% | +38.93% | +77.73% | 62.32B | |
| -3.21% | -5.72% | -17.12% | +350.96% | 27.07B | |
| -2.64% | -0.35% | -2.13% | -15.04% | 24.78B | |
| +0.71% | +8.50% | +27.76% | -15.29% | 20.59B | |
| -1.26% | -10.61% | +170.72% | +290.48% | 15.52B | |
| -0.22% | +1.62% | +44.31% | +167.58% | 14.49B | |
| +0.73% | +5.00% | -1.33% | +854.55% | 14.14B | |
| -0.54% | -0.30% | +27.33% | +202.19% | 12.35B | |
| Average | -0.66% | +1.68% | +37.21% | +223.74% | 29.13B | |
| Weighted average by Cap. | -0.59% | +1.39% | +35.79% | +161.34% |
Employees
-
